Bio Plus Co., Ltd (KOSDAQ:099430)

South Korea flag South Korea · Delayed Price · Currency is KRW
7,830.00
-250.00 (-3.09%)
Apr 25, 2025, 12:40 PM KST
21.96%
Market Cap 475.68B
Revenue (ttm) 66.41B
Net Income (ttm) 14.15B
Shares Out 58.87M
EPS (ttm) 246.92
PE Ratio 32.72
Forward PE n/a
Dividend 50.00 (0.64%)
Ex-Dividend Date Dec 27, 2024
Volume 377,411
Average Volume 753,905
Open 8,080.00
Previous Close 8,080.00
Day's Range 7,770.00 - 8,100.00
52-Week Range 4,250.00 - 8,390.00
Beta 0.60
RSI 63.01
Earnings Date May 15, 2025

About Bio Plus

Bio Plus Co., Ltd engages in the research and development, production, and sale of bio products in South Korea. It offers dermal fillers under the SkinPlus – Hyal, Bio+ Dew, HyalDew, DeneB Classic, Stilea, and 3-Senses brand names. The company also provides medical products, including InterBlock, an absorbable anti-adhesion barrier; Synofil, a synovial fluid replacement; and Blad-Care, a solution to temporarily improve cystitis symptoms. In addition, it offers mesotherapy products, such as skin rejuvenation products under the Kiara Reju name; S... [Read more]

Industry Surgical and Medical Instruments and Apparatus
Founded 2003
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 099430
Full Company Profile

Financial Performance

In 2024, Bio Plus's revenue was 66.41 billion, an increase of 2.10% compared to the previous year's 65.04 billion. Earnings were 14.15 billion, a decrease of -44.68%.

Financial Statements

News

There is no news available yet.